171 related articles for article (PubMed ID: 1689211)
1. Neurofilament and chromogranin expression in normal and neoplastic neuroendocrine cells of the human gastrointestinal tract and pancreas.
Perez MA; Saul SH; Trojanowski JQ
Cancer; 1990 Mar; 65(5):1219-27. PubMed ID: 1689211
[TBL] [Abstract][Full Text] [Related]
2. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
3. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract.
Miettinen M; Lehto VP; Dahl D; Virtanen I
Lab Invest; 1985 Apr; 52(4):429-36. PubMed ID: 2580121
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y
Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tumors of the gastrointestinal tract.
Chejfec G; Falkmer S; Askensten U; Grimelius L; Gould VE
Pathol Res Pract; 1988 Apr; 183(2):143-54. PubMed ID: 3290866
[TBL] [Abstract][Full Text] [Related]
6. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic pathology of gastrointestinal and pancreatic neuroendocrine tumours.
Wilander E
Acta Oncol; 1989; 28(3):363-9. PubMed ID: 2472824
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
Srivastava A; Hornick JL
Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
[TBL] [Abstract][Full Text] [Related]
11. Synaptophysin. A new marker for pancreatic neuroendocrine tumors.
Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE
Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010
[TBL] [Abstract][Full Text] [Related]
12. Chromogranins--new sensitive markers for neuroendocrine tumors.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
[TBL] [Abstract][Full Text] [Related]
13. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
Eberlein-Gonska M; Wiedenmann B; Waldherr R
Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
[No Abstract] [Full Text] [Related]
14. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms.
Moll R; Franke WW
Differentiation; 1985; 30(2):165-75. PubMed ID: 3007249
[TBL] [Abstract][Full Text] [Related]
16. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
17. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
Miettinen M
Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344
[TBL] [Abstract][Full Text] [Related]
18. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
Jirásek T; Hozák P; Mandys V
Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies.
Portel-Gomes GM; Grimelius L; Johansson H; Wilander E; Stridsberg M
Am J Surg Pathol; 2001 Oct; 25(10):1261-7. PubMed ID: 11688460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
